Solasto Corp
TSE:6197

Watchlist Manager
Solasto Corp Logo
Solasto Corp
TSE:6197
Watchlist
Price: 493 JPY -1.2% Market Closed
Market Cap: 46.6B JPY
Have any thoughts about
Solasto Corp?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

High Profitability Stocks
Health Care Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Solasto Corp

Revenue
136.3B JPY
Cost of Revenue
-114.1B JPY
Gross Profit
22.2B JPY
Operating Expenses
-20.4B JPY
Operating Income
1.8B JPY
Other Expenses
-2.1B JPY
Net Income
-280m JPY

Margins Comparison
Solasto Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
JP
Solasto Corp
TSE:6197
45.4B JPY
16%
1%
0%
US
Cigna Group
XMUN:CGN
88.5B EUR
11%
4%
1%
US
Cigna Corp
NYSE:CI
90.5B USD
11%
4%
1%
US
CVS Health Corp
NYSE:CVS
69.3B USD
14%
3%
1%
DE
Fresenius Medical Care AG
XMUN:FME
24B EUR
25%
7%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
19.9B USD
28%
9%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.5B EUR
23%
6%
-5%
US
Quest Diagnostics Inc
NYSE:DGX
17.6B USD
33%
14%
9%
US
DaVita Inc
NYSE:DVA
12.8B USD
33%
15%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12B EUR
25%
7%
3%
US
Chemed Corp
NYSE:CHE
8.5B USD
36%
17%
13%
Country JP
Market Cap 45.4B JPY
Gross Margin
16%
Operating Margin
1%
Net Margin
0%
Country US
Market Cap 88.5B EUR
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Country US
Market Cap 90.5B USD
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Country US
Market Cap 69.3B USD
Gross Margin
14%
Operating Margin
3%
Net Margin
1%
Country DE
Market Cap 24B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 19.9B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
3%
Country DE
Market Cap 18.5B EUR
Gross Margin
23%
Operating Margin
6%
Net Margin
-5%
Country US
Market Cap 17.6B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 12.8B USD
Gross Margin
33%
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 12B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 8.5B USD
Gross Margin
36%
Operating Margin
17%
Net Margin
13%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Solasto Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
Solasto Corp
TSE:6197
45.4B JPY
-1%
0%
4%
0%
US
Cigna Group
XMUN:CGN
88.5B EUR
7%
2%
10%
7%
US
Cigna Corp
NYSE:CI
90.5B USD
7%
2%
10%
7%
US
CVS Health Corp
NYSE:CVS
69.3B USD
7%
2%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
24B EUR
4%
2%
5%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
19.9B USD
5%
2%
8%
5%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.5B EUR
-6%
-2%
3%
1%
US
Quest Diagnostics Inc
NYSE:DGX
17.6B USD
13%
6%
10%
8%
US
DaVita Inc
NYSE:DVA
12.8B USD
104%
5%
13%
10%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12B EUR
4%
2%
5%
3%
US
Chemed Corp
NYSE:CHE
8.5B USD
27%
18%
29%
22%
Country JP
Market Cap 45.4B JPY
ROE
-1%
ROA
0%
ROCE
4%
ROIC
0%
Country US
Market Cap 88.5B EUR
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Country US
Market Cap 90.5B USD
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Country US
Market Cap 69.3B USD
ROE
7%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 24B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country US
Market Cap 19.9B USD
ROE
5%
ROA
2%
ROCE
8%
ROIC
5%
Country DE
Market Cap 18.5B EUR
ROE
-6%
ROA
-2%
ROCE
3%
ROIC
1%
Country US
Market Cap 17.6B USD
ROE
13%
ROA
6%
ROCE
10%
ROIC
8%
Country US
Market Cap 12.8B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
10%
Country DE
Market Cap 12B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country US
Market Cap 8.5B USD
ROE
27%
ROA
18%
ROCE
29%
ROIC
22%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top